Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Zura Bio Ltd (ZURA)

Zura Bio Ltd (ZURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Zura Bio Ltd 1489 W. Warm Springs Road Suite 110 Henderson NV 89014 USA

https://zurabio.com P: 702-757-6133

Description:

Zura Bio Limited is a clinical-stage biotechnology company advancing primary assets, including ZB-168 in Alopecia Areata and other inflammatory diseases and torudokimab in both chronic obstructive pulmonary disease and asthma. Zura Bio Limited, formerly known as JATT Acquisition Corp, is headquartered in London, UK.

Key Statistics

Overview:

Market Capitalization, $K 199,094
Enterprise Value, $K 99,284
Shares Outstanding, K 43,094
Annual Sales, $ 0 K
Annual Net Income, $ -69,240 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,280 K
EBIT, $ -62,650 K
EBITDA, $ -62,650 K
60-Month Beta 0.15
% of Insider Shareholders 15.80%
% of Institutional Shareholders 61.14%
Float, K 36,285
% Float 84.20%
Short Volume Ratio 0.57

Growth:

1-Year Return -7.60%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 11/13/23
Latest Earnings Date 05/10/24 [--]
Earnings Per Share ttm -4.25
EPS Growth vs. Prev Qtr 86.26%
EPS Growth vs. Prev Year -50.54%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ZURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -82.30%
Return-on-Assets % -66.71%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.36
Book Value/Share 1.85
Interest Coverage -2.25
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar